As per DelveInsight, the Small cell lung cancer market size is expected to increase at a CAGR of 15.2% during the study period (2017–30) attributing to a rich pipeline, healthcare spending, improved R&D, and discovery of novel targets.
Small cell lung cancer (SCLC) or Small cell lung carcinoma is an aggressive and most malignant form of tumor, characterized by uncontrolled, rapid growth of certain cells in the lungs. It accounts for almost 15% of all the lung cancers, the deadliest form of cancer in the world. Due to the belief of their origin from neuroendocrine cells (APUD cells) in the bronchus, SCLC is categorized as a type of neuroendocrine tumor of the lu...
